Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.

Abstract

Our results indicated that HULC is a novel molecule involved in osteosarcoma progression, which may provide a new marker of poor prognosis and a potential therapeutic target for osteosarcoma intervention.